Antengene Secures South Korean Approval for XPOVIO® in Combination Therapy for Multiple Myeloma

SHANGHAI and HONG KONG, Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmac...

October 18, 2024 | Friday | News
AbbVie Receives FDA Approval for VYALEV™: First Continuous Subcutaneous Infusion Therapy for Advanced Parkinson's Disease

AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has approved VYALEV™ (foscarbidopa and foslevodopa) as the first and o...

October 18, 2024 | Friday | News
Innovent Biologics Announces Successful Phase 2 Results for Picankibart in Treating Ulcerative Colitis

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

October 17, 2024 | Thursday | News
Eli Lilly's Mirikizumab Shows Promising Histologic Response in Phase 3 Study for Crohn's Disease, Outperforming Ustekinumab

Eli Lilly and Company (NYSE: LLY) announced data demonstrating more patients with moderately to severely active Crohn's disease treated with miri...

October 15, 2024 | Tuesday | News
Exelixis and MSD Announce Strategic Collaboration to Evaluate Zanzalintinib in Combination with KEYTRUDA® and WELIREG® for Advanced Cancers

Exelixis, Inc. (Nasdaq: EXEL) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that the companies have entered i...

October 15, 2024 | Tuesday | News
Dräger India Launches BabyRoo® TN 300, Transforming Newborn Care with Advanced Thermoregulation and Family-Centered Technologies

Dräger India is proud to announce the launch of the BabyRoo® TN 300 open warmer, with state-of-the-art thermoregulation capabilities as well as ad...

October 10, 2024 | Thursday | News
PROCEPT BioRobotics Launches FDA-Approved Trial Comparing Aquablation to Prostatectomy for Cancer Treatment

A Prospective, Randomized, Multicenter Study Assessing the Safety and Efficacy of Aquablation Therapy in Men with Grade Group 1 to 3 Localized Prostate C...

October 08, 2024 | Tuesday | News
NextGen Healthcare Expands AI-Driven Ambient Listening to Ophthalmologists and Optometrists

  NextGen Healthcare announced that its AI-driven ambient listening solution NextGen® Ambient Assist is now available to ophthalmologists and opt...

October 02, 2024 | Wednesday | News
Olympus Launches VISERA S1: A Major Advancement in ENT Imaging with Integrated Stroboscopy

Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced th...

October 01, 2024 | Tuesday | News
Metabolomics Diagnostics Develops PrePsia, an Innovative Test to Predict Preeclampsia Risk in Early Pregnancy

-Metabolomics Diagnostics, a deep-tech machine learning diagnostic platform developer, has developed an innovative test, PrePsia, to accurately predict t...

September 25, 2024 | Wednesday | News
Astellas Launches DIGITIVA™, a New Digital Health Solution for Heart Failure Management

New digital health solution for heart failure management puts patients at the center of their care by providing ability for at-home disease monitoring -...

September 19, 2024 | Thursday | News
BioNexus Gene Lab Corp. Invests RM 1 Million in Malaysian Healthcare Tech Firm Ascension Innovation

BioNexus Gene Lab Corp. (NASDAQ: BGLC), an emerging leader in genomic diagnostics and health technology, today announced the successful closing of its RM...

August 27, 2024 | Tuesday | News
Agilent Unveils Next-Generation J&W 5Q GC/MS Columns, Elevating Industry Standards in Chromatography

Agilent Technologies Inc.,  announced the release of its new Agilent J&W 5Q GC/MS Columns, representing a major advance in gas chromatogra...

August 16, 2024 | Friday | News
Eli Lilly Opens 346,000 sq. ft. Seaport Innovation Center as New Hub for Genetic Medicine and East Coast Gateway Labs

Lilly Seaport Innovation Center (LSC) serves as the central hub for Lilly's genetic medicines efforts and houses the first East Coast Lilly Gateway Labs ...

August 14, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close